Lv4
721 积分 2021-06-09 加入
Ocrelizumab-induced neutropenia: severity, recurrence, and management. A French national pharmacovigilance study
19天前
已关闭
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
1个月前
已完结
Factor XI/XIa Inhibitors: A New Approach to Anticoagulation
1个月前
已完结
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
1个月前
已完结
A Review on Comparison of Allopathic Medicines to other Drug Therapies in the Management of Asthma
2个月前
已完结
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation
2个月前
已完结
Narsoplimab Treatment for Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA) – Real World Outcomes from an Expanded Access Program
4个月前
已完结
Trial in Progress: An Open-Label, Multi-Center Phase 2 Study Evaluating Efficacy and Safety of the Masp-2 Inhibitor Narsoplimab in Pediatric Patients with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)
4个月前
已完结
Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive system
5个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
